Pharma Journalist -

Immuneed, a Swedish life science biotech company, today announced the publication of two key scientific publications, supporting both its immuno-service and its immuno-oncology…
Read More...

Gilead Sciences and its cell therapy subsidiary Kite announced that they have entered into a definitive agreement under which they have agreed to acquire Cell Design Labs, Inc., gaining…
Read More...

Acorda Therapeutics announced the resubmission of its New Drug Application (NDA) for INBRIJA to the U.S. Food and Drug Administration (FDA). INBRIJA is an investigational treatment for…
Read More...

Neon Therapeutics announced that it has entered a clinical trial collaboration with Merck (known as MSD outside the United States and Canada) to evaluate Neon Therapeutics’ proprietary…
Read More...

Concentric Analgesics announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to CA-008 for the treatment of post-surgical pain. CA-008 is a…
Read More...

Carmot Therapeutics, announced that it has entered into a multi-year drug discovery collaboration and licensing agreement with Amgen (Thousand Oaks, CA). As part of the agreement,…
Read More...

Advanced Clinical, a clinical development organization providing CRO, FSP, Quality & Validation, and Strategic Resourcing services, announced the opening of its new offices in…
Read More...

Genentech, a member of the Roche Group announced that the U.S. Food and Drug Administration (FDA) has granted full approval for Avastin (bevacizumab) for the treatment of adults with…
Read More...

Pfizer and Basilea Pharmaceutica announced that they have entered into an agreement whereby Pfizer will be granted the exclusive development and commercialization rights in China and…
Read More...

Kiadis Pharma announces that the first patient has been enrolled in the HATCY Phase 3 clinical trial for ATIR101. The multinational trial will evaluate the safety and efficacy of…
Read More...